Clinical Trial Update: Mechanism of Sorafenib Resistance in Patients With Advanced Hepatocellular Carcinoma [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial investigating mechanisms of sorafenib resistance in patients with advanced hepatocellular carcinoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Sorafenib (Sorafenib)

Snippet

Sponsor: King Saud University | Conditions: Hepatocellular Carcinoma | Phase 4 | Status: UNKNOWN